lodinated meta-iodobenzylguanidine (MIBG) scanning is a safe non-invasive method for locating extra-adrenal paragangliomas. However, a positive result is dependent on the presence of an uptake mechanism in the tumour. We report two cases of MIBG negative intracranial catecholamine secreting tumours successfully located by selective venous sampling and nuclear magnetic resonance scanning.
Introduction
Selective venous sampling accurately identifies phaeochromocytoma in the difficult sub-group of patients without an adrenal mass on computed tomography (CT).' Meta-iodobenzylguanidine (MIBG) scanning is also valuable in this situation,2 where it is the investigation of first choice since it is non-invasive. False negative MIBG scans do occur however. 2 We report two such cases: one, a tumour of the glomus jugulare, and one, the first described instance of a catecholamine secreting paraganglioma in the pterygopalatine fossa. In each, MIBG scanning was negative while selective venous sampling successfully located the tumours, which were further defined by nuclear magnetic resonance scanning (NMR). 
